Rifampicin and Rifampicin combination – Potential genotoxicity and associated contraceptive requirements
23/10/2026
Medicines for human use
Product information update (PIU)
The product information for the Rifampicin product range has been updated regarding potential genotoxicity
Product information
- Product name
- Rifadin and Rifater
- Active substance
- Rifampicin & Rifampicin combination
- Authorisation holder
- Sanofi-aventis Ireland Ltd
- Authorisation number
-
PA0540/066/001-004
PA0540/067/001
PA0540/068/001-002
- Human or veterinary medicine
-
Human